Modulating these specific immune mediators is highly relevant to the psychological improvements observed, as depression has been associated with peripheral over-activation of the IL-23/IL-17 pathway64, and increased levels of TNF-α and IL-1265,66. The gene discussed is IL17A; the disease is major depressive disorder.